Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1993 1
1997 1
2008 1
2009 1
2012 1
2013 4
2014 4
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
Dual time point 2-deoxy-2-[18F]fluoro-D-glucose PET/CT: nodal staging in locally advanced breast cancer.
García Vicente AM, Soriano Castrejón A, Cruz Mora MÁ, Ortega Ruiperez C, Espinosa Aunión R, León Martín A, González Ageitos A, Van Gómez López O. García Vicente AM, et al. Among authors: cruz mora ma. Rev Esp Med Nucl Imagen Mol. 2014 Jan-Feb;33(1):1-5. doi: 10.1016/j.remn.2013.03.005. Epub 2013 May 23. Rev Esp Med Nucl Imagen Mol. 2014. PMID: 23707190 Clinical Trial.
Glycolytic activity with 18F-FDG PET/CT predicts final neoadjuvant chemotherapy response in breast cancer.
García Vicente AM, Cruz Mora MÁ, León Martín AA, Muñoz Sánchez Mdel M, Relea Calatayud F, Van Gómez López O, Espinosa Aunión R, Gonzalez Ageitos A, Soriano Castrejón A. García Vicente AM, et al. Among authors: cruz mora ma. Tumour Biol. 2014 Nov;35(11):11613-20. doi: 10.1007/s13277-014-2495-7. Epub 2014 Aug 20. Tumour Biol. 2014. PMID: 25139100
Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: a multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group.
Provencio M, Cruz Mora MÁ, Gómez-Codina J, Quero Blanco C, Llanos M, García-Arroyo FR, de la Cruz L, Gumá Padró J, Delgado Pérez JR, Sánchez A, Alvarez Cabellos R, Rueda A; Gotel (Spanish Lymphoma Oncology Group). Provencio M, et al. Among authors: cruz mora ma. Leuk Lymphoma. 2014 Jan;55(1):51-5. doi: 10.3109/10428194.2013.790544. Epub 2013 Jun 12. Leuk Lymphoma. 2014. PMID: 23573825 Clinical Trial.
Semi-quantitative lymph node assessment of (18)F-FDG PET/CT in locally advanced breast cancer: correlation with biological prognostic factors.
García Vicente AM, Soriano Castrejón A, Cruz Mora MA, González Ageitos A, Muñoz Sánchez Mdel M, León Martín A, Espinosa Aunión R, Relea Calatayud F, Muñoz Madero V, Chacón López-Muñiz I, Cordero García JM, Jiménez Londoño GA. García Vicente AM, et al. Among authors: cruz mora ma. Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):72-9. doi: 10.1007/s00259-012-2244-3. Epub 2012 Sep 28. Eur J Nucl Med Mol Imaging. 2013. PMID: 23053321 Clinical Trial.
Effectiveness of daily versus non-daily granulocyte colony-stimulating factors in patients with solid tumours undergoing chemotherapy: a multivariate analysis of data from current practice.
Almenar Cubells D, Bosch Roig C, Jiménez Orozco E, Álvarez R, Cuervo JM, Díaz Fernández N, Sánchez Heras AB, Galán Brotons A, Giner Marco V, Codes M De Villena M; LEARN II Study Group. Almenar Cubells D, et al. Eur J Cancer Care (Engl). 2013 May;22(3):400-12. doi: 10.1111/ecc.12043. Epub 2013 Jan 18. Eur J Cancer Care (Engl). 2013. PMID: 23331323 Free PMC article.
A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia.
Mel JR, Salar A, Rodríguez CA, Alegre A, González A, Cassinello J, Montesinos J, Gasquet JA, Sánchez J, Saigí E; AMG-DAR-2002-01 Study Group. Mel JR, et al. Curr Med Res Opin. 2008 Oct;24(10):2931-42. doi: 10.1185/03007990802381323. Epub 2008 Sep 4. Curr Med Res Opin. 2008. PMID: 18775103 Clinical Trial.
Early and delayed prediction of axillary lymph node neoadjuvant response by (18)F-FDG PET/CT in patients with locally advanced breast cancer.
García Vicente AM, Soriano Castrejón Á, León Martín A, Relea Calatayud F, Muñoz Sánchez Mdel M, Cruz Mora MÁ, Jiménez Londoño GA, Espinosa Aunión R. García Vicente AM, et al. Among authors: cruz mora ma. Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1309-18. doi: 10.1007/s00259-013-2657-7. Epub 2014 Apr 18. Eur J Nucl Med Mol Imaging. 2014. PMID: 24744045 Clinical Trial.
13 results